Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients

To enhance the therapeutic index of allogeneic hematopoietic stem cell transplantation (HSCT), we immunized ten HLA-matched sibling donors prior to stem cell collection with recipient-derived clonal myeloma immunoglobulin, idiotype (Id), as a tumor antigen, conjugated with keyhole limpet hemocyanin...

Descripción completa

Detalles Bibliográficos
Autores principales: Foglietta, Myriam, Neelapu, Sattva S., Kwak, Larry W., Jiang, Yunfang, Nattamai, Durga, Lee, Seung-Tae, Fowler, Daniel H., Sportes, Claude, Gress, Ronald E., Steinberg, Seth M., Vence, Luis M., Radvanyi, Laszlo, Dwyer, Karen C., Qazilbash, Muzzaffar H., Bryant, Kelly, Bishop, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469751/
https://www.ncbi.nlm.nih.gov/pubmed/22773122
http://dx.doi.org/10.1038/bmt.2012.132

Ejemplares similares

Ejemplares similares